DRUG DISCONTINUATIONS IN THE UNITED-KINGDOM AND THE UNITED-STATES, 1964 TO 1983 - ISSUES OF SAFETY

被引：73

作者：

BAKKE, OM ^{[1
]}

WARDELL, WM ^{[1
]}

LASAGNA, L ^{[1
]}

机构：

[1] UNIV ROCHESTER,MED CTR,DEPT PHARMACOL,CTR STUDY DRUG DEV,ROCHESTER,NY 14642

来源：

关键词：

D O I：

10.1038/clpt.1984.78

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：559 / 567

页数：9

共 14 条

[1] COOPER P, 1971, ADVERSE REACTIONS DR
[2] DAVIES DM, 1981, TXB ADVERSE DRUG REA
[3] DIGGLE GE, 1982, PHARM INT, V3, P230
[4] RESEARCH ACTIVITY ON SYSTEMIC CONTRACEPTIVE DRUGS BY THE UNITED-STATES PHARMACEUTICAL-INDUSTRY, 1963-1976
DIRADDO, J
WARDELL, WM
[J]. CONTRACEPTION, 1981, 23 (04) : 345 - 365
[5] DUKES MNG, 1983, SIDE EFFECTS DRUGS, V7
[6] Gilman AG, 1980, PHARM BASIS THERAPEU
[7] A SURVEY OF PRODUCTS LICENSED IN THE UNITED-KINGDOM FROM 1971-1981
GRIFFIN, JP
DIGGLE, GE
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (04) : 453 - 463
[8] Griffiths M. C., 1982, USAN USP DICT DRUG N
[9] MODELL W, 1983, DRUGS CHOICE
[10] Reynolds J. E. F., 1982, MARTINDALE EXTRA PHA